Stock Events

Stock Events

Cullinan Therapeutics (CGEM) Q3 2024 Earnings

8AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.99

-0.84

-0.69

-0.54

Details

Expected EPS

-0.725089

Actual EPS

-0.75

Surprise EPS

-0.02

Surprise Percent

+3.44%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.75 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.